← Back to all trials
Not Yet Recruiting
NCT05650151
Peri-operative Vitamin D Therapy for Hepatectomy
Conditions: Vitamin D Deficiency, Hepatocellular Carcinoma, Perioperative Complication
Sex: All
Ages: 20 Years – N/A
Phase: NA
Enrollment: 200
Sponsor: National Taiwan University Hospital
Summary
The goal of this double-blind, randomized controlled trial is to test the effect of short-term and high-dose vitamin D therapy in patients undergoing hepatectomy for hepatocellular carcinoma.
Eligibility Criteria
Inclusion Criteria:Patients older than 20 yearsPatients will undergo hepatectomy for hepatocellular carcinoma.Exclusion Criteria:Patients with hypercalcemia, hyperparathyroidism, sarcoidosis, multiple myeloma
Source: ClinicalTrials.gov (NCT05650151). StuddyBuddy aggregates publicly available trial information.
